IL-21-IgFc immunotherapy alters transcriptional landscape of lymph node cells leading to enhanced flu vaccine response in aging and SIV infection
© 2023 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd..
Aging people living with HIV (PWH) frequently manifest impaired antibody (Ab) responses to seasonal flu vaccination which has been attributed to ongoing inflammation and immune activation. We have recently reported a similar scenario in old simian immunodeficiency virus (SIV) infected rhesus macaques (RM) with controlled viremia and have been able to compensate for this deficiency by immunotherapy with interleukin (IL)-21-IgFc. To understand the underlying mechanisms of IL-21-induced immunomodulation leading to enhanced flu vaccine response in aging and SIV, we have investigated draining lymph node (LN) cells of IL-21-treated and -untreated animals at postvaccination. We observed IL-21-induced proliferation of flu-specific LN memory CD4 T cells, expansion of B cells expressing IL-21 receptor (IL-21R), and modest expansion of T follicular helper cells (Tfh) co-expressing T-cell immunoreceptor with Ig and ITIM domains (TIGIT) and DNAX accessory molecule (DNAM-1). Transcriptional analysis of LN cells of IL-21-treated animals revealed significant inhibition of germinal center (GC) Tfh and B-cell interferon signaling pathways along with enhanced B-cell development and antigen presentation pathways. We conclude that IL-21 treatment at the time of flu vaccination in aging SIV-infected animals modulates the inductive LN GC activity, to reverse SIV-associated LN Tfh and B-cell dysfunction. IL-21 is a potential candidate molecule for immunotherapy to enhance flu vaccine responses in aging PWH who have deficient antibody responses.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
Aging cell - 22(2023), 11 vom: 15. Nov., Seite e13984 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pallikkuth, Suresh [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 17.11.2023 Date Revised 29.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/acel.13984 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362097585 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM362097585 | ||
003 | DE-627 | ||
005 | 20231226090525.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/acel.13984 |2 doi | |
028 | 5 | 2 | |a pubmed24n1206.xml |
035 | |a (DE-627)NLM362097585 | ||
035 | |a (NLM)37712598 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pallikkuth, Suresh |e verfasserin |4 aut | |
245 | 1 | 0 | |a IL-21-IgFc immunotherapy alters transcriptional landscape of lymph node cells leading to enhanced flu vaccine response in aging and SIV infection |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.11.2023 | ||
500 | |a Date Revised 29.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd. | ||
520 | |a Aging people living with HIV (PWH) frequently manifest impaired antibody (Ab) responses to seasonal flu vaccination which has been attributed to ongoing inflammation and immune activation. We have recently reported a similar scenario in old simian immunodeficiency virus (SIV) infected rhesus macaques (RM) with controlled viremia and have been able to compensate for this deficiency by immunotherapy with interleukin (IL)-21-IgFc. To understand the underlying mechanisms of IL-21-induced immunomodulation leading to enhanced flu vaccine response in aging and SIV, we have investigated draining lymph node (LN) cells of IL-21-treated and -untreated animals at postvaccination. We observed IL-21-induced proliferation of flu-specific LN memory CD4 T cells, expansion of B cells expressing IL-21 receptor (IL-21R), and modest expansion of T follicular helper cells (Tfh) co-expressing T-cell immunoreceptor with Ig and ITIM domains (TIGIT) and DNAX accessory molecule (DNAM-1). Transcriptional analysis of LN cells of IL-21-treated animals revealed significant inhibition of germinal center (GC) Tfh and B-cell interferon signaling pathways along with enhanced B-cell development and antigen presentation pathways. We conclude that IL-21 treatment at the time of flu vaccination in aging SIV-infected animals modulates the inductive LN GC activity, to reverse SIV-associated LN Tfh and B-cell dysfunction. IL-21 is a potential candidate molecule for immunotherapy to enhance flu vaccine responses in aging PWH who have deficient antibody responses | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a IL-21 and Tfh cells | |
650 | 4 | |a IL-21 and vaccine response | |
650 | 4 | |a aging and SIV | |
650 | 4 | |a aging and immune response | |
650 | 4 | |a immunomodulation in aging | |
650 | 7 | |a interleukin-21 |2 NLM | |
650 | 7 | |a MKM3CA6LT1 |2 NLM | |
650 | 7 | |a Influenza Vaccines |2 NLM | |
650 | 7 | |a Interleukins |2 NLM | |
700 | 1 | |a Kvistad, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Sirupangi, Tirupataiah |e verfasserin |4 aut | |
700 | 1 | |a Kizhner, Alexander |e verfasserin |4 aut | |
700 | 1 | |a Pahwa, Rajendra |e verfasserin |4 aut | |
700 | 1 | |a Cameron, Mark J |e verfasserin |4 aut | |
700 | 1 | |a Richardson, Brian |e verfasserin |4 aut | |
700 | 1 | |a Williams, Sion |e verfasserin |4 aut | |
700 | 1 | |a Ayupe, Ana |e verfasserin |4 aut | |
700 | 1 | |a Brooks, Marissa |e verfasserin |4 aut | |
700 | 1 | |a Petrovas, Constantinos |e verfasserin |4 aut | |
700 | 1 | |a Villinger, Francois |e verfasserin |4 aut | |
700 | 1 | |a Pahwa, Savita |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Aging cell |d 2002 |g 22(2023), 11 vom: 15. Nov., Seite e13984 |w (DE-627)NLM126391149 |x 1474-9726 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2023 |g number:11 |g day:15 |g month:11 |g pages:e13984 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/acel.13984 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2023 |e 11 |b 15 |c 11 |h e13984 |